Company Overview of Lafitte Ventures, Ltd.
Lafitte Ventures, Ltd. focuses on developing, producing, and shipping dried marihuana strains for various medical conditions in Canada. It focuses on producing dried marihuana strains that range from high CBD strains to 50/50 strains to high THC strains for personal chemistry and preferred uses. The company was founded in 2013 and is based in Nanaimo, Canada.
PO Box 55029
Southgate Mall PO
Nanaimo, BC V9R 0B6
Founded in 2013
Key Executives for Lafitte Ventures, Ltd.
Lafitte Ventures, Ltd. does not have any Key Executives recorded.
Lafitte Ventures, Ltd. Key Developments
Tilray Introduces Medical Cannabis Capsules in Canada
May 29 17
Tilray announced that medical cannabis liquid capsules are now available for Tilray patients in Canada. At Tilray, extraction methods preserve the delicate cannabinoid content of the plant and ensure Tilray capsules are precisely formulated. Capsules are vegetarian with a sunflower lecithin carrier oil and are currently available in two varieties, T200 (10mg THC per capsule) and TC100 (2.5mg THC and 2.5mg CBD per capsule), with more varieties in development. Tilray currently supplies GMP-grade medical cannabis products – including whole flower, oils, and capsules – to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers around the world for commercial, compassionate access and research purposes. Tilray became the first medical cannabis producer in North America to be certified in accordance with the European Medicines Agency's (EMA) Good Manufacturing Practice (GMP) standards in December 2016. GMP certification is the most rigorous standard that manufacturers of pharmaceutical products must meet in their production processes, and it provides regulators and health care providers in countries new to medical cannabis with certainty that Tilray products are the safe and smart choice.
Tilray Unveils New Product Categorization System in Canada
May 15 17
Tilray unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada. Tilray Profiles are a set of nine easy-to-understand categories that apply to all Tilray products available to patients in Canada, including whole flower, blends, oil drops, and capsules. With Tilray Profiles, products are categorized according to the potency of the active cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). The name of each profile features a letter and a number. The letter indicates the balance of THC and CBD: “T” indicates THC-dominant products, “C” indicates CBD-dominant products, and “TC” indicates a balanced ratio of both cannabinoids. The number following the letter reflects the potency of the product: 100 for low-potency, 200 for medium, and 300 for high. For example, a medium-potency THC-dominant strain of flower would be categorized under the T200 profile. Each of the nine profiles corresponds to a color, which means that patients can browse the Tilray store and easily determine which products meet their needs. To reflect these changes, Tilray will begin to roll out new packaging for all cannabis products sold in Canada. Strain name and category (sativa, indica, hybrid, and CBD) will continue to be available on the Tilray store and printed on packaging labels for all whole flower cannabis products.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries